There are 1105 resources available
278P - Efficacy and safety of cadonilimab plus lenvatinib in previously immunotherapy treated advanced/metastatic clear cell renal cell carcinoma (ccRCC): A multicenter, single-arm, phase II trial
Presenter: Jiwei Huang
Session: Poster Display session
Resources:
Abstract
279P - Avelumab maintenance therapy in older patients with advanced urothelial carcinoma in Japan: Subgroup analyses of data from post-marketing surveillance by age group
Presenter: Masayoshi Nagata
Session: Poster Display session
Resources:
Abstract
280P - Efficacy of avelumab + axitinib (A + Ax) vs sunitinib (S) by number of IMDC risk factors in patients (pts) with advanced renal cell carcinoma (aRCC): Subgroup analyses from the final analysis of the phase III JAVELIN renal 101 trial
Presenter: John Haanen
Session: Poster Display session
Resources:
Abstract
281P - Intrinsic molecular difference between bladder and upper tract urothelial carcinomas and its impacts in treatment response
Presenter: Jiwon Kim
Session: Poster Display session
Resources:
Abstract
282P - Prognostic outcome of neoadjuvant chemotherapy for non-metastatic muscle-invasive bladder cancer (MIBC) patients: Real-world data from clinical practice at Siriraj Hospital
Presenter: Parinpat Angsuwarangsee
Session: Poster Display session
Resources:
Abstract
283P - Diagnostic efficacy of urine DNA methylation based screening tests for surveillance in NMIBC: A qualitative analysis
Presenter: Gunn Goel
Session: Poster Display session
Resources:
Abstract
284P - Real-world efficacy of lenvatinib and pembrolizumab as first-line therapy in patients with metastatic renal cell carcinoma with high burden disease
Presenter: Olesya Stativko
Session: Poster Display session
Resources:
Abstract
285P - Genetic variation of the inflammatory cytokine Interleukin 17 in non-muscle invasive bladder cancer
Presenter: Mukul Singh
Session: Poster Display session
Resources:
Abstract
286P - Radiotherapy outcomes of patients with bladder cancer who are unfit for cystectomy: A retrospective cohort study
Presenter: Koyo Kikuchi
Session: Poster Display session
Resources:
Abstract
287P - RC48-ADC alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma with HER2 low/null expression: A multicenter, real-world, retrospective study
Presenter: daining Wang
Session: Poster Display session
Resources:
Abstract